Please login to the form below

Not currently logged in
Email:
Password:

GW Pharmaceuticals promotes Adam George to MD

And Scott Giacobello joins as chief financial officer

UK biopharma company GW Pharmaceuticals has promoted chief financial officer Adam George to UK managing director.

To fill the CFO role GW has recruited Scott Giacobello, who will be based at its US headquarters in Carlsbad, California.

George’s role is a newly-created one that encompasses broad leadership responsibilities for UK operations and sees him report to the company’s CEO Justin Gover.

Gover said: “These important leadership appointments reflect GW’s continuing evolution into a transatlantic commercial-stage biopharmaceutical company.

“Scott’s significant financial and accounting expertise will be a major asset to the organisation as we make that shift.

“In addition, with Adam having served as CFO since 2012, his new managing director - UK role leverages the broad knowledge he has of our business and provides continuity of strong senior UK-based leadership, essential elements to our continued success.”

George has been with GW since 2007, joining as company secretary and financial controller and will continue to serve as its company secretary.

In his new role he will be tasked with ensuring GW’s UK operations achieve their strategic and operational goals.

Giacobello, meanwhile, has 25 years experience in finance and operations, most recently as CFO for Chase Pharmaceuticals until its acquisition last year by Allergan.

Prior to that, From 2008 to 2015, he held senior level finance positions at Allergan.

13th March 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics